A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 30 Apr 2017
At a glance
- Drugs Insulin degludec/liraglutide (Primary) ; Insulin degludec; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DUAL-I-Japan
- Sponsors Novo Nordisk
- 07 Jun 2017 Biomarkers information updated
- 24 Feb 2017 Planned End Date changed from 1 Dec 2017 to 25 Dec 2017.
- 24 Feb 2017 Planned primary completion date changed from 1 Dec 2017 to 25 Dec 2017.